Science Explorer Interactive view Map
Company · San Bruno · United States

Neoleukin Therapeutics (United States)

neoleukin.comROR OpenAlex
Research works
72
▲ 402% vs 2013–17
Citations
723
10.1 per fractional work
Top-10% rate
6.4%
record average 16.5%
Open access
37%
world 28%

Not ranked overall: Neoleukin Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.12× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.66× its world share, 6 worksBiochemistry, Geneti…Immunology and Microbiology: 18.57× its world share, 4 worksImmunology and Micro…Neuroscience: 0.85× its world share, 0 worksNeuroscienceChemistry: 0.44× its world share, 0 worksChemistryComputer Science: 0.62× its world share, 1 worksComputer ScienceEngineering: 0.14× its world share, 0 worksEngineeringMaterials Science: 0.39× its world share, 0 worksMaterials ScienceMathematics: 0.58× its world share, 0 worksMathematicsMedicine: 2.20× its world share, 10 worksMedicineArts and Humanities: 0.24× its world share, 0 worksArts and HumanitiesPsychology: 0.15× its world share, 0 worksPsychologySocial Sciences: 0.11× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 18.6×. Every wedge is a field page.

Which keywords describe research at Neoleukin Therapeutics (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Immunotherapy, Tumor Regression, Cancer Immunotherapy, Tumor Microenvironment, Lymphoma, CAR T Cells, Chimeric Antigen Receptor and Immune Checkpoint Blockade.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 22 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 22 words, with their numbers
  1. Immunotherapy5▲ 28×5 topics
  2. Tumor Regression4▲ 164×2 topics
  3. Cancer Immunotherapy4▲ 108×2 topics
  4. Tumor Microenvironment4▲ 35×5 topics
  5. Lymphoma3▲ 83×2 topics
  6. CAR T Cells3▲ 163×1 topic
  7. Chimeric Antigen Receptor3▲ 163×1 topic
  8. Cancer2▲ 6.4×9 topics
  9. Immune Checkpoint Blockade2▲ 79×1 topic
  10. PD-1 and PD-L12▲ 79×1 topic
  11. Tumor Targeting2▲ 45×3 topics
  12. Gene Therapy2▲ 39×2 topics
  13. NK Cell Recognition2▲ 114×1 topic
  14. Natural Killer Cells2▲ 114×1 topic
  15. Innate Immunity2▲ 22×4 topics
  16. Arginine Deprivation1▲ 166×1 topic
  17. Bacterial Therapy1▲ 166×1 topic
  18. Glycosylation1▲ 52×3 topics
  19. Cancer Therapy1▲ 9.4×5 topics
  20. Immunity1▲ 12×2 topics
  21. Antigen Presentation1▲ 52×1 topic
  22. Dendritic Cells1▲ 50×1 topic

Which research topics does Neoleukin Therapeutics (United States) publish most on?

By volume in 2022–2025: CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Immune Cell Function and Interaction and Cancer Research and Treatments.

CAR-T cell therapy resea…3CAR-T cell therapy research: 3 fractional worksCancer Immunotherapy and Biomarkers: 2 fractional worksImmune Cell Function and Interaction: 2 fractional worksCancer Research and Treatments: 1 fractional worksImmunotherapy and Immune Responses: 1 fractional worksMonoclonal and Polyclona…1Monoclonal and Polyclonal Antibodies Research: 1 fractional worksT-cell and B-cell Immunology: 1 fractional worksProtein Tyrosine Phosphatases: 1 fractional worksCancer, Hypoxia, and Metabolism: 1 fractional worksCytokine Signaling Pathways and Interactions: 0 fractional works
OncologyImmunologyBiotechnologyRadiology, Nuclear Medicine and Imaging2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CAR-T cell therapy research Oncology 3 works
  2. 2 Cancer Immunotherapy and Biomarkers Oncology 2 works
  3. 3 Immune Cell Function and Interaction Immunology 2 works
  4. 4 Cancer Research and Treatments Biotechnology 1 works
  5. 5 Immunotherapy and Immune Responses Immunology 1 works
  6. 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  7. 7 T-cell and B-cell Immunology Immunology 1 works
  8. 8 Protein Tyrosine Phosphatases Molecular Biology 1 works
  9. 9 Cancer, Hypoxia, and Metabolism Cancer Research 1 works
  10. 10 Cytokine Signaling Pathways and Interactions Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available36.8%not open63.2%

World: 28% of research is openly available.

with international co-authors18.9%domestic only81.1%

World: 19% is written across borders.

How has Neoleukin Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 402% higher than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in San Bruno

All research institutions in San Bruno

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.